share_log

Citigroup | SC 13G: Statement of acquisition of beneficial ownership by individuals-Citigroup Global Markets Limited(5.01%),Citigroup Global Markets Holdings Bahamas Limited(5.01%), etc.

Citigroup | SC 13G: Statement of acquisition of beneficial ownership by individuals-Citigroup Global Markets Limited(5.01%),Citigroup Global Markets Holdings Bahamas Limited(5.01%), etc.

花旗集團 | SC 13G:超過5%持股股東披露文件-Citigroup Global Markets Limited(5.01%),Citigroup Global Markets Holdings Bahamas Limited(5.01%)等
美股SEC公告 ·  13:33

Moomoo AI 已提取核心訊息

Citigroup Inc. and its affiliates have filed a Schedule 13G with the Securities and Exchange Commission on November 12, 2024, indicating a beneficial ownership of 5.01% in Puretech Health Plc. The filing, which details ownership of 12,004,514 ordinary shares, was made in accordance with SEC rules 13d-1(b), (c), and (d) and amendments thereto filed pursuant to rule 13d-2. The entities involved in the filing include Citigroup Global Markets Limited, Citigroup Global Markets Holdings Bahamas Limited, Citigroup Financial Products Inc., Citigroup Global Markets Holdings Inc., and Citigroup Inc. The filing indicates that the shares are held in the ordinary course of business and not for the purpose of changing or influencing the control of the issuer. The principal business offices for the entities are located in London, England, Nassau, Bahamas, and New York, NY.
Citigroup Inc. and its affiliates have filed a Schedule 13G with the Securities and Exchange Commission on November 12, 2024, indicating a beneficial ownership of 5.01% in Puretech Health Plc. The filing, which details ownership of 12,004,514 ordinary shares, was made in accordance with SEC rules 13d-1(b), (c), and (d) and amendments thereto filed pursuant to rule 13d-2. The entities involved in the filing include Citigroup Global Markets Limited, Citigroup Global Markets Holdings Bahamas Limited, Citigroup Financial Products Inc., Citigroup Global Markets Holdings Inc., and Citigroup Inc. The filing indicates that the shares are held in the ordinary course of business and not for the purpose of changing or influencing the control of the issuer. The principal business offices for the entities are located in London, England, Nassau, Bahamas, and New York, NY.
花旗集團及其關聯公司於2024年11月12日向證券交易委員會提交了13G表格,表明在puretech health plc中擁有5.01%的股權。該申報詳細說明了擁有12,004,514普通股的所有權,符合SEC規則13d-1(b),(c),和(d)以及根據規則13d-2提交的修訂。提交申報的實體包括花旗全球市場有限公司、花旗全球市場控股巴哈馬有限公司、花旗金融產品公司、花旗全球市場控股公司以及花旗集團。申報顯示這些股份是在日常業務過程中持有的,而非爲了改變或影響發行人的控制。這些實體的主要業務辦公室位於英格蘭倫敦、巴哈馬拿騷和紐約紐約。
花旗集團及其關聯公司於2024年11月12日向證券交易委員會提交了13G表格,表明在puretech health plc中擁有5.01%的股權。該申報詳細說明了擁有12,004,514普通股的所有權,符合SEC規則13d-1(b),(c),和(d)以及根據規則13d-2提交的修訂。提交申報的實體包括花旗全球市場有限公司、花旗全球市場控股巴哈馬有限公司、花旗金融產品公司、花旗全球市場控股公司以及花旗集團。申報顯示這些股份是在日常業務過程中持有的,而非爲了改變或影響發行人的控制。這些實體的主要業務辦公室位於英格蘭倫敦、巴哈馬拿騷和紐約紐約。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息